278 related articles for article (PubMed ID: 23939511)
1. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
Morley KC; Leung S; Baillie A; Haber PS
Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
[TBL] [Abstract][Full Text] [Related]
2. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.
Morley KC; Baillie A; Fraser I; Furneaux-Bate A; Dore G; Roberts M; Abdalla A; Phung N; Haber PS
Br J Psychiatry; 2018 Jun; 212(6):362-369. PubMed ID: 29716670
[TBL] [Abstract][Full Text] [Related]
3. Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial.
Rombouts SA; Baillie A; Haber PS; Morley KC
Alcohol Alcohol; 2019 May; 54(3):272-278. PubMed ID: 30977770
[TBL] [Abstract][Full Text] [Related]
4. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
5. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
[TBL] [Abstract][Full Text] [Related]
6. High-dose baclofen for treatment-resistant alcohol dependence.
Pastor A; Jones DM; Currie J
J Clin Psychopharmacol; 2012 Apr; 32(2):266-8. PubMed ID: 22367662
[TBL] [Abstract][Full Text] [Related]
7. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Vonghia L; Mirijello A; Abenavoli L; D'Angelo C; Caputo F; Zambon A; Haber PS; Gasbarrini G
Lancet; 2007 Dec; 370(9603):1915-22. PubMed ID: 18068515
[TBL] [Abstract][Full Text] [Related]
10. Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis.
Yamini D; Lee SH; Avanesyan A; Walter M; Runyon B
Alcohol Alcohol; 2014; 49(4):453-6. PubMed ID: 24939964
[TBL] [Abstract][Full Text] [Related]
11. Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study.
Morley KC; Lagopoulos J; Logge W; Baillie A; Adams C; Haber PS
Addict Biol; 2020 Jan; 25(1):e12702. PubMed ID: 30561840
[TBL] [Abstract][Full Text] [Related]
12. Moderation of baclofen response by a GABA
Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS
Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397
[TBL] [Abstract][Full Text] [Related]
13. [Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence].
Krupitsky EM; Rybakova KV; Kiselev AS; Alexeeva YV; Berntsev VA; Chekhlaty EI; Zubova EY; Popov YV; Neznanov NG
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):53-62. PubMed ID: 26356398
[TBL] [Abstract][Full Text] [Related]
14. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates.
Gorsane MA; Kebir O; Hache G; Blecha L; Aubin HJ; Reynaud M; Benyamina A
Subst Abus; 2012; 33(4):336-49. PubMed ID: 22989277
[TBL] [Abstract][Full Text] [Related]
15. Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection.
Leggio L; Ferrulli A; Zambon A; Caputo F; Kenna GA; Swift RM; Addolorato G
Addict Behav; 2012 Apr; 37(4):561-4. PubMed ID: 22244707
[TBL] [Abstract][Full Text] [Related]
16. [Baclofen for alcohol addiction].
Helland A; Bramness JG
Tidsskr Nor Laegeforen; 2011 Nov; 131(21):2132-3. PubMed ID: 22048211
[TBL] [Abstract][Full Text] [Related]
17. Executive Functioning Moderates Responses to Appetitive Cues: A Study in Severe Alcohol Use Disorder and Alcoholic Liver Disease.
Logge WB; Morley KC; Haber PS; Baillie AJ
Alcohol Alcohol; 2019 Jan; 54(1):38-46. PubMed ID: 30576416
[TBL] [Abstract][Full Text] [Related]
18. A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic.
Owens L; Thompson A; Rose A; Gilmore I; Pirmohamed M; Richardson P
Alcohol; 2017 Aug; 62():11-15. PubMed ID: 28755747
[TBL] [Abstract][Full Text] [Related]
19. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
[TBL] [Abstract][Full Text] [Related]
20. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
